Doesn't make SENS (19) 升勢不似預期 未放sens 想去死
含鳩啦八婆
1001 回覆
5 Like
0 Dislike
第 1 頁第 2 頁第 3 頁第 4 頁第 5 頁第 6 頁第 7 頁第 8 頁第 9 頁第 10 頁第 11 頁第 12 頁第 13 頁第 14 頁第 15 頁第 16 頁第 17 頁第 18 頁第 19 頁第 20 頁第 21 頁第 22 頁第 23 頁第 24 頁第 25 頁第 26 頁第 27 頁第 28 頁第 29 頁第 30 頁第 31 頁第 32 頁第 33 頁第 34 頁第 35 頁第 36 頁第 37 頁第 38 頁第 39 頁第 40 頁第 41 頁
就快回家了
3.47
大家都係2-4橫行左好耐
冇30都15啦
冇30都15啦
俾個翻譯笑死左
想要但都知無可能
收聲啦 
一陣比你燈到唔批再跌落地核
一陣比你燈到唔批再跌落地核
無可能都要留個名先
已經見到個結局
Pop子去到邊都比人屌
好彩未見到麵神
好慘，去到邊到俾人鬧
講講吓入左黎就仆啦
有冇正文
好想知入面講乜嘢
好想知入面講乜嘢
呢隻值博率高唔高？
同你講唔高你係咪唔會買？
大家對我有D誤會
真係將可樂拉埋黎講
見到ko係咪講緊飲可樂會有糖尿病
你快過我
一開始邊位師兄將可樂拉埋同sens講先
Source: MAHATHIR MOHD YASIN / Shutterstock.com
Recently, continuous glucose monitoring (CGM) device manufacturer Senseonics (NYSEAMERICAN:SENS) has been generating headlines thanks to its strong following on social media. But the underlying CGM device is also worthy of its own praise, which allows diabetes patients greater freedom. Not wanting to be left behind, other companies, including Abbott Laboratories (NYSE:ABT) also have their own CGM equipment.
Eventually, the biotechnology industry may even get rid of monitoring and management solutions and finally cure the condition. Of course, there’s not much of a profitability incentive in cures as opposed to management. Moreover, you have companies like Coca-Cola, which is not exactly helping the situation when it comes to facilitating societal health.
I’m not suggesting that Coca-Cola is in the business of giving people diabetes. But take this warning from Healthline.com: “Drinking high amounts of sugar-sweetened beverages — such as soda — can have various adverse impacts on your health. These range from increased chances of tooth decay to a higher risk of heart disease and metabolic disorders like type 2 diabetes.”
7 Top Defensive Stocks To Buy For Q2 Earnings Season
Certainly, there’s personal choice involved. However, because sugary sodas are addictive, Coca-Cola is not going to get a pass regarding this list of vice stocks. It’s a sin play, no doubt about it but it could be a long-term profitable one.
一開始邊位師兄將可樂拉埋同sens講先
Source: MAHATHIR MOHD YASIN / Shutterstock.com
Recently, continuous glucose monitoring (CGM) device manufacturer Senseonics (NYSEAMERICAN:SENS) has been generating headlines thanks to its strong following on social media. But the underlying CGM device is also worthy of its own praise, which allows diabetes patients greater freedom. Not wanting to be left behind, other companies, including Abbott Laboratories (NYSE:ABT) also have their own CGM equipment.
Eventually, the biotechnology industry may even get rid of monitoring and management solutions and finally cure the condition. Of course, there’s not much of a profitability incentive in cures as opposed to management. Moreover, you have companies like Coca-Cola, which is not exactly helping the situation when it comes to facilitating societal health.
I’m not suggesting that Coca-Cola is in the business of giving people diabetes. But take this warning from Healthline.com: “Drinking high amounts of sugar-sweetened beverages — such as soda — can have various adverse impacts on your health. These range from increased chances of tooth decay to a higher risk of heart disease and metabolic disorders like type 2 diabetes.”
7 Top Defensive Stocks To Buy For Q2 Earnings Season
Certainly, there’s personal choice involved. However, because sugary sodas are addictive, Coca-Cola is not going to get a pass regarding this list of vice stocks. It’s a sin play, no doubt about it but it could be a long-term profitable one.
唔記得啦，好似頭幾個post已經有人講，但10幾先開始post相叫人飲多啲可樂